Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
Plos One|December 6, 2011
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MSDouglas S Goodin, Jason Jones, David Li, et al.Clinical Therapeutics|October 8, 2009
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational studyGeorge C Ebers, Anthony T Reder, Anthony Traboulsee, et al.The Journal of Clinical Investigation|April 28, 2023
Clostridium epsilon toxin is excessive in multiple sclerosis and provokes multifocal lesions in mouse modelsAnthony T RederMultiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2020
Thoracic flexion provokes circumferential dysesthesia: A symptom of thoracic cord lesions in MSAnthony T RederJournal of Neurology, Neurosurgery, and Psychiatry|December 24, 2011
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosisDouglas S Goodin, Anthony Traboulsee, Volker Knappertz, et al.BMC Neurology|October 30, 2010
The genetic basis of multiple sclerosis: a model for MS susceptibilityDouglas S GoodinAnnals of Neurology|March 28, 2006
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?Douglas S GoodinJournal of Neurology, Neurosurgery, and Psychiatry|July 3, 2024
Pathogenesis of multiple sclerosis: genetic, environmental and random mechanismsDouglas S GoodinJournal of Neurology|November 19, 2004
Disease-modifying therapy in MS: a critical review of the literature. Part II: Assessing efficacy and dose-responseDouglas S GoodinPlos One|December 29, 2012
The genetic and environmental bases of complex human-disease: extending the utility of twin-studiesDouglas S GoodinPageof 13